Vaccination has been the most widely used strategy to protect against viral infections for centuries. However, the molecular mechanisms governing the long-term persistence of immunological memory in response to vaccines remain unclear.
The ability of the immune system to maintain long-term memory against pathogens is critical for rapid induction of immunity upon later infections 1 . Initial exposure to antigens leads to the activation and considerable expansion of antigen-specific lymphocytes, most of which are removed by programmed cell death after the immune response subsides [2] [3] [4] . However, a small number of these antigenspecific lymphocytes survive and develop into memory cells 5, 6 . The selective retention of antigen-specific memory lymphocytes after an immune response is crucial for the maintenance of long-term immunological memory [5] [6] [7] [8] [9] .
Memory B cells represent a heterogeneous population of quiescent antigen-experienced, long-lived B cells 7, 8, 10 . Memory B cells can be generated in response to both T cell-dependent and T cell-independent antigens. Following T cell-dependent antigen stimulation, the interaction of B cells with T cells leads to the formation of germinal centers (GCs), where B cells undergo isotype switching and somatic hypermutations in the immunoglobulin genes 7 . These antigen-specific GC B cells can give rise to memory B cells or plasma cells 7, 11, 12 . After reencountering the antigens, memory B cells rapidly proliferate and differentiate into antibody-secreting plasma cells (ASCs) to produce high-affinity antibodies that neutralize antigens 8, 12, 13 . Antibodydependent immune responses are important for protection against viral infections 14 . Influenza viruses cause annual epidemic and sometimes pandemic infections that pose major health threats to the human population worldwide 15, 16 . Influenza vaccines that elicit effective protection typically contain the major viral surface proteins hemagglutinin (HA) and neuraminidase. Induction of memory B cells and neutralizing antibodies against these antigens effectively protects humans from subsequent infection by influenza [17] [18] [19] .
Long-term survival of memory B cells occurs independently of the persistence of the original antigens 20 . B cell lymphoma-2 (Bcl-2) family members that govern mitochondrion-dependent cell death pathways may regulate memory B cell survival [21] [22] [23] . However, the full mechanisms for the protection of memory B cells from cell death remain unclear. Autophagy is important for maintaining cell survival and has a critical role in immune regulation [24] [25] [26] [27] . Autophagy may be especially important for sustaining the survival of long-lived cell types, such as neurons 28, 29 . ASCs also depend on autophagy for survival through inhibiting endoplasmic reticulum stress that arises from vigorous immunoglobulin secretion 30 . The long-lived memory B cells are capable of proliferating and generating high titers of secondary antibody responses after reencountering the antigens. However, whether autophagy promotes the long-term survival of memory B cells is unknown. Here we present data to show that, in mice, autophagy is essential for the maintenance of memory B cells against influenza infection. Enhancing autophagy may provide a new means to protect memory B cells and improve the efficacy of vaccination.
RESULTS

Decreased cell death and active autophagy in memory B cells
We compared apoptosis signaling in antigen-specific GC and memory B cells from mice immunized with 4-hydroxy-3-nitrophenylacetyl conjugated to keyhole limpet hemocyanin (NP-KLH). NP-specific GC B cells (IgM − IgD − CD11b − Ly6G − CD138 − (DUMP − ) and a r t i c l e s 5 0 4 VOLUME 20 | NUMBER 5 | MAY 2014 nature medicine B220 + IgG1 + NP + CD38 − ), but not memory B cells (DUMP − B220 + IgG1 + NP + CD38 + ), showed rapid cell death after in vitro culture ( Fig. 1a and Supplementary Fig. 1a ). Accordingly, NP-specific GC B cells showed activation of caspase-9 and caspase-3 by intracellular staining, whereas NP-specific memory B cells lacked detectable caspase activation ( Fig. 1b) . We observed similar results in influenza HA-specific memory B cells ( Fig. 1a,b) . These data suggest that the development of memory B cells from GC B cells is accompanied by increased resistance to cell death. To investigate whether autophagy might protect long-lived memory B cells, we first measured autophagy in B cells by examining the processed form of microtubule-associated protein light chain 3 (LC3) that is characteristic of autophagosome formation 31 . We detected LC3 punctate staining in memory B cells, but not GC B cells ( Fig. 1c) . As shown by real-time RT-PCR, compared to naive B cells and other B cell subsets, memory B cells expressed increased levels of Ulk1 (Atg1), Becn1 (Atg6), Rb1cc1, Atg14 and Uvrag, which are critical for autophagy initiation [32] [33] [34] [35] [36] , as well as Atg5, Atg7, Map1lc3a, Map1lc3b and Gabarap, which are required for autophagosome maturation 37 ( Fig. 1d and Supplementary Fig. 1a,b) . These results suggest that memory B cells display constitutively active autophagy.
Requirement for autophagy in memory B cell survival
An autophagy inhibitor, 3-methyladenine 38 , accelerated cell death in memory B cells expressing markers of autophagy ( Supplementary Fig. 1c-e ).
To determine whether autophagy protects memory B cells in vivo, we generated mice with B cell-specific deletion of Atg7 (B/Atg7 −/− ) by crossing Cd19-cre mice with Atg7 flox/flox mice 39 (Supplementary Fig. 2a ). Although the peritoneal CD5 + B-1a cell number was reduced owing to the defect in autophagy, as observed before in Atg5-deficient mice 40 , the development of conventional B cells was not affected in B/Atg7 −/− mice ( Supplementary Fig. 2b-d) . Atg7 deficiency increased the turnover rates of B-1a cells but not conventional B cells in vitro and in vivo ( Fig. 2a and Supplementary Fig. 3a-d) . We found that both NP-and influenza HA-specific Atg7 −/− memory B cells underwent significantly increased spontaneous cell death, whereas cell death in GC B cells was not affected by autophagy deficiency ( Fig. 2a and Supplementary Fig. 3e ), suggesting that autophagy protects memory B cells from undergoing cell death.
We found no significant activation of caspase-9 or caspase-3 in Atg7 −/− memory B cells undergoing spontaneous cell death ( Fig. 2b) , suggesting that autophagy deficiency triggers caspase-independent cell death in memory B cells. Antigen-specific memory B cells and GC B cells showed similar levels of the known antiapoptotic proteins Bcl-xL and myeloid cell leukemia-1 (Mcl-1) by intracellular staining; however, memory B cells expressed more Bcl-2 than GC B cells ( Supplementary Fig. 4 ). Moreover, deletion of Atg7 did not change the expression of any of these Bcl-2 family molecules in GC and memory B cells ( Supplementary Fig. 4 ), suggesting that increased cell death of Atg7 −/− memory B cells is not owing to reduced expression of Bcl-2, Bcl-xL or Mcl-1. Higher expression of Bcl2 mRNA in memory B cells than in GC B cells has been observed previously in mice 41 . GC B cells in humans express low levels of Bcl-2 and display a propensity for apoptosis 42 , whereas transgenic overexpression of Bcl-2 in B cells leads to the accumulation of memory B cells, especially those expressing low-affinity immunoglobulin 21 . Increased levels of Bcl-2 probably contributes to the resistance of memory B cells to mitochondrion-dependent activation of caspases even in the absence of autophagy.
Defective secondary antibody responses in B/Atg7 −/− mice We next examined whether autophagy deficiency might affect primary and memory B cell responses. Primary antibody responses at day 14 after immunization with NP-KLH, including the production of high-affinity and total (including high-and low-affinity) anti-NP IgG subclasses and anti-NP IgM, were comparable in B/Atg7 −/− mice and wild-type controls ( Fig. 3a and Supplementary Fig. 5a,b) . The numbers of NP-specific IgM or IgG1 ASCs were similar in the npg spleen and bone marrow of B/Atg7 −/− mice and wild-type controls 2 weeks after primary immunization ( Supplementary Figs. 5c and 6a) .
The numbers of GC B cells (B220 + Fas + cells expressing the T cell and B cell activation marker GL7) detected by flow cytometry or immunocytochemistry staining (FITC-conjugated anti-GL7-labeled cells) were comparable in immunized B/Atg7 −/− mice and wild-type controls ( Supplementary Fig. 6b-d) . These results suggest that early primary antibody responses, including GC formation, affinity maturation and class switching, are largely normal in B/Atg7 −/− mice. A moderate reduction in anti-NP IgG1 antibody levels in B/Atg7 −/− mice 6 weeks after immunization ( Supplementary Fig. 6e ) is possibly due to the loss of ASCs deficient in autophagy 30 . In contrast to normal early primary antibody responses, there was a severe reduction in secondary anti-NP IgG1 antibody production in B/Atg7 −/− mice (Fig. 3b) . The number of ASCs secreting anti-NP IgG1 was also severely reduced by approximately tenfold in the spleens and bone marrow of B/Atg7 −/− mice ( Fig. 3c,d) . This indicates that autophagy is required for secondary antibody responses to T cell-dependent antigens.
Oxidative stress and lipid peroxidation in Atg7 −/− memory B cells Given the defective secondary antibody responses in B/Atg7 −/− mice, we sought to determine whether the generation or maintenance of memory B cells might be defective in these mice. B/Atg7 −/− mice showed a marked reduction in numbers of NP-specific memory B cells 8 weeks after immunization ( Fig. 4a,b) . The generation of NP-specific memory B cells was normal at weeks 1 and 2 after primary immunization in B/Atg7 −/− mice ( Fig. 4c ). However, we detected a rapid decline in memory B cells thereafter in B/Atg7 −/− mice ( Fig. 4c) . B/Atg7 −/− mice also showed a reduced memory B cell response after immunization with a different protein antigen, ovalbumin, suggesting that reduction in memory B cells is not specific for a particular antigen ( Supplementary Fig. 7) . These data indicate that memory B cells could be generated initially but were unable to persist in B/Atg7 −/− mice, thereby providing an explanation for the defective secondary antibody responses observed in these mice.
Consistent with a lack of caspase activation in Atg7 −/− memory B cells ( Fig. 2b) , a pancaspase inhibitor, quinolyl-valyl-O-methylaspartyl-[2,6-difluorophenoxy]-methyl ketone (qVD-oph) 43 , did not protect these cells from cell death ( Fig. 4d) . Inhibitors of receptorinteracting protein-1-dependent necrosis, including necrostatin-1 and necrostatin-5 (ref. 44 ), also did not inhibit cell death (Fig. 4d) . In contrast, a necrosis inhibitor targeting oxidative stress, NecroX-2 (ref. 45 ), showed significant inhibition of cell death in Atg7 −/− memory B cells ( Fig. 4d) . Moreover, the reactive oxygen species (ROS) scavenger N-acetyl-l-cysteine (NAC) and tempol 46, 47 a r t i c l e s 5 0 6 VOLUME 20 | NUMBER 5 | MAY 2014 nature medicine memory B cells from cell death ( Fig. 4d ). This indicates that oxidative stress mediates cell death in autophagy-deficient memory B cells. Autophagy is known to promote the clearance of dysfunctional mitochondria 48 , and it has been shown that dysfunctional mitochondria can produce excessive ROS to induce cell death 49 . Immunocytochemistry showed that disruption of mitochondrial membrane potential with an uncoupling agent, carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) 49 , increased the number of autophagosomes that colocalized with mitochondria in memory B cells (Fig. 4e) . This supports the possibility that autophagy is involved in the clearance of dysfunctional mitochondria in memory B cells. We detected a decrease in mitochondrial membrane potentials in Atg7 −/− memory B cells by tetramethylrhodamine ethyl ester (TMRE) staining ( Fig. 4f) , which indicates that Atg7 −/− memory B cells harbor dysfunctional mitochondria. We also detected increased production of ROS by MitoSOX red staining in Atg7 −/− memory npg B cells (Fig. 4f) , which suggests that defective autophagy leads to the accumulation of dysfunctional mitochondria and the increased generation of ROS. Lipid peroxidation may induce cell death during oxidative stress 50 . We detected significant lipid peroxidation with BODIPY 581/591 C11 (ref. 51) in Atg7 −/− memory B cells after in vitro culture (Fig. 4g) . Such increases in BODIPY staining were inhibited by α-tocopherol (α-Toc), an antioxidant that is efficient in suppressing lipid peroxidation 52 (Fig. 4g) . Notably, α-Toc also inhibited cell death in Atg7 −/− memory B cells (Fig. 4g) . These results suggest that oxidative stress-induced cell death of autophagy-deficient memory B cells involves lipid peroxidation.
Rescue of Atg7 −/− memory B cells in vivo
To further determine whether increased production of ROS contributes to the loss of Atg7 −/− memory B cells in vivo, we injected antioxidant NAC intraperitoneally (i.p.) into B/Atg7 −/− and control mice following immunization with NP-KLH. We observed that continuous administration of NAC decreased ROS levels in memory B cells from immunized B/Atg7 −/− mice (Fig. 4h) . NAC also partially rescued memory B cells and secondary antibody responses in B/Atg7 −/− mice (Fig. 4h) , supporting the role for the suppression of ROS production by autophagy in the protection of memory B cell survival. Injection with α-Toc i.p. was effective in suppressing lipid peroxidation in memory B cells in B/Atg7 −/− mice (Fig. 4i) . α-Toc also partially restored memory B cells and secondary antibody responses to NP in B/Atg7 −/− mice (Fig. 4i) , indicating that elevated lipid peroxidation contributes to the loss of memory B cells in B/Atg7 −/− mice.
Alox5 is a major lipoxygenase that catalyzes membrane lipid peroxidation and has been implicated in promoting cell death [53] [54] [55] . We therefore crossed B/Atg7 −/− with Alox5 −/− mice. We found that additional deletion of Alox5 suppressed the induction of membrane lipid peroxidation in Atg7 −/− memory B cells during in vitro culture (Fig. 4j) . Deletion of Alox5 also partially rescued memory B cells and secondary antibody responses to NP in B/Atg7 −/− mice ( Fig. 4j and  Supplementary Fig. 8) . These results suggest that Alox5-dependent membrane lipid peroxidation is involved in the accelerated cell death of autophagy-deficient memory B cells.
Impaired memory B responses to influenza in B/Atg7 −/− mice
We next sought to determine whether the memory immune response against influenza A viruses is dependent on autophagy. Infection with influenza A induced influenza HA-specific IgG and IgA memory B cells in the spleen and lung of wild-type mice (Fig. 5a,b and Supplementary Fig. 9 ). However, the numbers of these memory B cells were significantly lower in B/Atg7 −/− mice (Fig. 5a,b) . The production of secondary anti-HA IgG or IgA antibodies was also severely impaired in B/Atg7 −/− mice after rechallenge with the influenza virus ( Fig. 5c) . Moreover, B/Atg7 −/− mice showed significantly decreased numbers of IgG and IgA ASCs after rechallenge with influenza A (Fig. 5d) . In contrast, T cell activation in response to primary or secondary influenza virus infection was not defective in B/Atg7 −/− mice (Supplementary Fig. 10 ). Together, these data suggest that autophagy in B cells is essential for the maintenance of protective memory B cell responses against influenza infections. After immunization with a sublethal dose of influenza A virus, wild-type mice were completely protected from a lethal rechallenge with the virus 2 months later (Fig. 6a) . Wild-type immunized mice were also protected from the loss of body weight typically associated with lethal influenza A infections (Fig. 6b) . In contrast, 70% of the immunized B/Atg7 −/− mice died by 2 weeks after rechallenge with a lethal dose of influenza A (Fig. 6a) . All the immunized B/Atg7 −/− mice also showed significant loss of body weight after influenza rechallenge (Fig. 6b) . Histological analyses demonstrated extensive lung destruction and leukocyte infiltration in the lungs of the rechallenged B/Atg7 −/− mice (Fig. 6c) . Consistent with these observations, we found significant numbers of macrophages, neutrophils and lymphocytes in the bronchoalveolar lavage (BAL) fluid of the lethally rechallenged B/Atg7 −/− mice (Fig. 6d) . Immunized B/Atg7 −/− mice displayed 10,000-fold higher viral titers in the lung 4 d after re-infection than wild-type controls (Fig. 6e) , indicating that B/Atg7 −/− mice were unable to efficiently clear the influenza virus. Together, these data suggest that immunization of B/Atg7 −/− mice failed to induce protective humoral immunity to control influenza virus re-infection. Despite the major role of antibodies in protection against influenza infections, T cell responses may also confer some protection [56] [57] [58] . B/Atg7 −/− mice surviving the re-infection still showed defective anti-HA antibody responses but displayed increased T cell expansion, especially of T helper type 17 cells (Supplementary Fig. 10c-e) . The increased T helper type 17 cell expansion in these surviving B/Atg7 −/− mice could be caused by compensatory T cell responses to higher influenza virus loads ( Fig. 6e) and may contribute to the survival of a portion of B/Atg7 −/− mice after virus re-infection.
We next examined whether it is possible to improve memory B cell responses by promoting autophagy. Rapamycin can induce autophagy by inhibiting its target, mTOR 59 . Indeed, we found that rapamycin increased autophagosome formation and improved the survival of wild-type memory B cells (Supplementary Fig. 11a-c) . Rapamycin also enhanced the ability of adoptively transferred wild-type memory B cells to protect B/Atg7 −/− mice against influenza infection (Supplementary Fig. 11d ), suggesting that inducing autophagy can promote memory B cell functions. Autophagy is likely to be important for the maintenance of memory B cells with different antigen specificities, such as those specific for influenza neuraminidase ( Supplementary Fig. 12a ). We also detected autophagosomes in human influenza HA-specific memory B cells ( Supplementary  Fig. 12b) , which suggests that it may be possible to promote autophagy in human memory B cells and improve protection against influenza viruses after vaccination.
DISCUSSION
In the present study, we found that autophagy plays an essential part in the maintenance of memory B cells in mice. Deletion of Atg7 in B cells led to severe loss of memory B cells and decreased secondary antibody responses against influenza infection. B/Atg7 −/− mice immunized with influenza virus remained susceptible to infection and showed a marked inability to clear the virus that was accompanied by severe lung destruction, loss of body weight and high mortality.
Our data suggest a molecular mechanism for autophagy in the maintenance of immunological memory through protection of memory B cell survival.
Memory B cells expressed more Bcl-2 than GC B cells, which may contribute to the lower susceptibility of memory B cells to apoptosis. Notably, transgenic overexpression of Bcl-2 in B cells favors the accumulation of memory B cells expressing low-affinity IgG 21 , suggesting that the Bcl-2-regulated apoptosis pathway may affect immunoglobulin affinity maturation. In contrast, B/Atg7 −/− mice showed loss of memory B cells and defects in the production of both high-and lowaffinity IgGs to similar extents, indicating that autophagy may primarily regulate the survival of B cells after immunoglobulin affinity maturation. Therefore, our study suggests that autophagy inhibits cell death that is distinct from the intrinsic cell death pathway controlled by Bcl-2 family members. npg
We found no significant caspase activation in memory B cells. Moreover, autophagy deficiency did not induce caspase activation in memory B cells, indicating that the increased cell death in autophagydeficient memory B cells is different from classic apoptosis that involves caspase activation. We detected decreases in mitochondrial membrane potential and increased ROS production in autophagydeficient memory B cells. Autophagy may be critical for mitochondria quality control to prevent ROS production. The in vivo rescue of memory B cells by treatment with α-Toc or by deletion of Alox5 in B/Atg7 −/− mice suggests that oxidative stress and membrane lipid peroxidation promote cell death in autophagy-deficient memory B cells. Lipid peroxidation may induce organelle stress with the disruption of organelle membranes, such as those of the nucleus, mitochondria and lysosomes 50 . Disruption of membrane integrity may cause rapid cell death due to organelle malfunctions.
Our data suggest a critical role for autophagy in the maintenance of immunological memory against influenza infection. B cell subsets involved in short-term immune responses do not depend on autophagy to maintain their survival. Quiescent antigen-experienced long-lived memory B cells can rapidly proliferate and differentiate into ASCs upon reencountering antigens, leading to the production of high-affinity antibodies at high titers that can effectively neutralize pathogens. These long-lived memory B cells would have increased potential for accumulating dysfunctional organelles. Our study indicates that autophagy provides a molecular mechanism for the protection of long-lived memory B cells through quality control of cellular organelles. Promoting autophagy and inhibiting oxidative stress during immunization prolonged the survival of memory B cells and increased secondary antibody production. Constitutive autophagy has been detected in human memory B cells, and studies to further demonstrate that autophagy is required for maintaining memory B cells in humans are currently underway. Our study may have implications for vaccine design and suggests that targeting autophagy and oxidative stress pathways are potentially effective means to improve the efficacy of vaccination against infections.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
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We thank M. Komatsu adoptively transferred intravenously (1 × 10 4 per mouse) into B/Atg7 −/− recipient mice. Sorted B220 + CD23 + IgM low IgD + naive B cells (2 × 10 5 per mouse) from unimmunized B/Atg7 −/− mice were co-injected as filler cells to minimize cell loss during injection. One day after the transfer, B/Atg7 −/− recipients were re-infected with a lethal dose (2,500 TCID 50 ) of influenza virus. Some groups were treated i.p. with rapamycin 61 (LC Laboratories; 75 µg per kg body weight) daily from day -1 to day 13 during infection (ten mice per group). Weight loss and survival of the recipient mice were monitored for 14 d.
Determination of lung viral titers. On days 4 and 8 after infection with influenza A, mouse lungs were collected and rinsed in sterile water to lyse excess red blood cells. Lungs were resuspended in DMEM and homogenized using a glass bead beater (Biospec Products). Samples were diluted in DMEM containing 0.05% trypsin (Worthington Biochemical) and centrifuged for 10 min at 9,000 r.p.m., and supernatants were serially diluted in 96-well round-bottom plates (Fisher Scientific). Samples were then transferred to 96-well roundbottom plates containing Madin-Darby canine kidney (MDCK) cell monolayers. Lung dilutions and MDCK cells were allowed to incubate for 4 d and then were visualized for characteristic adherence of turkey red blood cells (Fitzgerald Industries).
Counting the number of bronchoalveolar lavage fluid cells. BAL fluid collection and quantitation of airway cells were carried out as previously described 62 . BAL cells were collected by serially instilling and withdrawing 0.8-ml aliquots of PBS (pH 7.2) twice from the tracheal cannula. Aliquots of 1 × 10 5 cells were centrifuged onto glass slides, stained using modified Giemsa and used to determine the absolute numbers of BAL fluid cells.
